Literature DB >> 31860798

A Mechanism-Based Sphingosine-1-phosphate Lyase Inhibitor.

Guillem Pons1, Daniel Riba1, Mireia Casasampere1,2, Eduardo Izquierdo1,2, José-Luís Abad1, Gemma Fabriàs1,3, Pilar G Rodríguez Ortega4, Juan J López-González4, Manuel Montejo4, Josefina Casas1,3, Antonio Delgado1,2.   

Abstract

The synthesis of a series of vinylated analogues of sphingosine-1-phosphate together with their unambiguous configurational assignment by VCD methods is reported. Among them, compound RBM10-8 can irreversibly inhibit human sphingosine-1-phosphate lyase (hS1PL) while behaving also as an enzyme substrate. These findings, together with the postulated mechanism for S1PL activity, reinforce the role of RBM10-8 as a new mechanism-based hS1PL inhibitor.

Entities:  

Year:  2020        PMID: 31860798     DOI: 10.1021/acs.joc.9b02420

Source DB:  PubMed          Journal:  J Org Chem        ISSN: 0022-3263            Impact factor:   4.354


  2 in total

Review 1.  Druggable Sphingolipid Pathways: Experimental Models and Clinical Opportunities.

Authors:  Victoria A Blaho
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

2.  Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice.

Authors:  Anabel S De la Garza-Rodea; Steven A Moore; Jesus Zamora-Pineda; Eric P Hoffman; Karishma Mistry; Ashok Kumar; Jonathan B Strober; Piming Zhao; Jung H Suh; Julie D Saba
Journal:  Int J Mol Sci       Date:  2022-07-08       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.